🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This retrospective cohort study aims to improve our understanding of the cu...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-05-06
Trial ID
NCT01064349
A study to compare the safety and efficacy of an aromatase inhibitor in com...
Status
Completed
Location
Novartis Investigative Site
Start Date
2011-05-05
Trial ID
NCT01160211
Treatments Being Tested
This study will compare the anti-tumor efficacy of apricoxib and lapatinib/...
Status
Terminated
Location
Arizona Clinical Research Center
Start Date
2008-04
Trial ID
NCT00657137
Treatments Being Tested
This is a Phase II, randomized, open-label, multi-center study evaluating t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2011-10
Trial ID
NCT01137994
Treatments Being Tested
This is a Phase III, randomized, multicenter, international, 2-arm, open-la...
Status
Completed
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00829166
Treatments Being Tested
The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab...
Status
Completed
Location
Southern Cancer Center
Start Date
2017-12-15
Trial ID
NCT03262935
Treatments Being Tested
This is a prospective, open-label, real-word study evaluating the efficacy ...
Status
Unknown
Location
Xijing Hospital
Start Date
2016-07
Trial ID
NCT03273595
Treatments Being Tested
This is a randomized controlled trial of HER-2 positive breast cancer patie...
Status
Unknown
Location
PUMCH
Start Date
2017-03-01
Trial ID
NCT03085368
Treatments Being Tested
This study is an open-label, dose-escalation study of MM-111 with five diff...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2011-01
Trial ID
NCT01304784
The purpose of this study is to estimate the clinical benefit of lapatinib ...
Status
Withdrawn
Location
Charite Campus Mitte II. Medizinische Klinik Hämatologie und Onkologie
Start Date
2013-09
Trial ID
NCT01985893
Treatments Being Tested